Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Rvmd Stock Analysis Revolution Medicines Inc Trades Near 99 With Mild Daily Gain 20260403 1 Is Ermenegildo Zgn Stock A Safe Investment Price At 10.72 Up 1.61 20260406 Is 36Kr Krkr Stock Good For Passive Investors Price At 3.62 Down 11.71 20260407 Is Sfl Corporation Sfl Stock A Safe Investment Price At 10.95 Up 0.18 20260406 The real value proposition of Clarivate CLVT stock Buying Pressure 20260506 What Perspective CATX is doing that smarter investors notice Slides 20260508 Is Cohen COHN stock worth taking a position in The moat Fortress Biotech FBIO is building for long term dominance Slides 20260508 Amesite AMST Reports Q1 2026 Results EPS 016 Meets Consensus Marc Jacobs Departs LVMH After Nearly Three Decades Retains Creative Role Under New Ownership Forbes 2026 AI 50 Unveils Leading Artificial Intelligence Companies Driving Global Innovation Amazon Signs Direct Copper Deal with US Mine as AI Boom Fuels Metal Demand Indivior Pharmaceuticals INDV Stock Today Drops 060 Key Support at 3471 20260518 Intellia Therapeutics NTLA Drops 665 Key Support at 1266 20260514 Europes Household Energy Prices Surge After Iran Conflict Gas Costs Spike Across EU Capitals CB Financial CBFV Slips 178 Testing 3258 Support 20260517 How Required Minimum Distributions in 2026 Could Affect Your Social Security Benefits EbolaDriven Isolation Mandate for DR Congo Players Raises Questions About World Cup Logistics and Economic Impact Trump Health Speculation Raises Market Uncertainty Persistent Pessimism US Consumer Sentiment Remains Sour Amid Inflation Geopolitical Tensions and Trade Policy Uncertainty Travel Insurance for Foreign Trips Understanding War Exclusions and Coverage Details Bessent Sees Substantial Disinflation Ahead as Warsh Assumes Fed Leadership GlobalFoundries GFS Surges Over 5 as Semiconductor Sector Gathers Momentum Enanta Pharmaceuticals ENTA Dips 3 as Support at 1285 Comes into Focus Enliven Therapeutics ELVN Faces Pressure as Shares Dip 168 Key Support Levels in Focus DRDGOLD DRD Slips 4 as Gold Pullback Tests Key Support at 2481